Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Sep 7;12(9):1418-1427.
doi: 10.2215/CJN.02100217. Epub 2017 Aug 4.

Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD

Sankar D Navaneethan  1   2 , Stacey E Jolly  3 , Jesse D Schold  4   5 , Susana Arrigain  4 , Georges Nakhoul  5 , Victoria Konig  4 , Jennifer Hyland  5 , Yvette K Burrucker  5 , Priscilla Davis Dann  5 , Barbara H Tucky  5 , John Sharp  6 , Joseph V Nally  5
Affiliations
Randomized Controlled Trial

Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD

Sankar D Navaneethan et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: Patient navigators and enhanced personal health records improve the quality of health care delivered in other disease states. We aimed to develop a navigator program for patients with CKD and an electronic health record-based enhanced personal health record to disseminate CKD stage-specific goals of care and education. We also conducted a pragmatic randomized clinical trial to compare the effect of a navigator program for patients with CKD with enhanced personal health record and compare their combination compared with usual care among patients with CKD stage 3b/4.

Design, setting, participants, & measurements: Two hundred and nine patients from six outpatient clinics (in both primary care and nephrology settings) were randomized in a 2×2 factorial design into four-study groups: (1) enhanced personal health record only, (2) patient navigator only, (3) both, and (4) usual care (control) group. Primary outcome measure was the change in eGFR over a 2-year follow-up period. Secondary outcome measures included acquisition of appropriate CKD-related laboratory measures, specialty referrals, and hospitalization rates.

Results: Median age of the study population was 68 years old, and 75% were white. At study entry, 54% of patients were followed by nephrologists, and 88% were on renin-angiotensin system blockers. After a 2-year follow-up, rate of decline in eGFR was similar across the four groups (P=0.19). Measurements of CKD-related laboratory parameters were not significantly different among the groups. Furthermore, referral for dialysis education and vascular access placement, emergency room visits, and hospitalization rates were not statistically significant different between the groups.

Conclusions: We successfully developed a patient navigator program and an enhanced personal health record for the CKD population. However, there were no differences in eGFR decline and other outcomes among the study groups. Larger and long-term studies along with cost-effectiveness analyses are needed to evaluate the role of patient navigators and patient education through an enhanced personal health record in those with CKD.

Keywords: Aged; Ambulatory Care Facilities; Cost-Benefit Analysis; Electronic Health Records; Emergency Service, Hospital; Follow-Up Studies; Health Records, Personal; Humans; Nephrologists; Outcome Assessment (Health Care); Patient Care Planning; Patient Navigation; Primary Health Care; Referral and Consultation; Renal Insufficiency, Chronic; Renin-Angiotensin System; hospitalization; kidney disease; navigator; nephrology; personal health record; renal dialysis.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Flow diagram shows recruitment process (screening, randomization, and follow-up of study participants).
Figure 2.
Figure 2.
Slope of decline in eGFR among the four study groups during follow-up.
See this image and copyright information in PMC

Comment in

References

    1. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, Morgenstern H, Pavkov ME, Saran R, Powe NR, Hsu CY; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team : Trends in prevalence of chronic kidney disease in the united states. Ann Intern Med 165: 473–481, 2016 - PMC - PubMed
    1. United States Renal Data System. 2016 USRDS Annual Data Report: Expenditures for Persons with CKD. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016
    1. Narva AS, Norton JM, Boulware LE: Educating patients about CKD: The path to self-management and patient-centered care. Clin J Am Soc Nephrol 11: 694–703, 2016 - PMC - PubMed
    1. Kuhn L, Reeves K, Taylor Y, Tapp H, McWilliams A, Gunter A, Cleveland J, Dulin M: Planning for action: The impact of an asthma action plan decision support tool integrated into an electronic health record (EHR) at a large health care system. J Am Board Fam Med 28: 382–393, 2015 - PubMed
    1. Mortimer NJ, Rhee J, Guy R, Hayen A, Lau AY: A web-based personally controlled health management system increases sexually transmitted infection screening rates in young people: A randomized controlled trial. J Am Med Inform Assoc 22: 805–814, 2015 - PMC - PubMed

Publication types

MeSH terms